Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Authors:
- 19 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (19) , 17243-17258
Abstract
To effectively inhibit the growth and metastasis of non-small cell lung cancer (NSCLC) and overcome its multidrug resistance (MDR), we designed and synthesized a series of rhodium (Rh, III) 2-benzoylpyridine thiosemicarbazone complexes. Through studying their structure-activity relationships, we identified the Rh(III) complex (Rh4) with excellent cytotoxicity against multidrug-resistant lung cancer cells (A549/ADR cells). Additionally, we successfully constructed an apoferritin (AFt) nanoparticle (NP) delivery system (AFt-Rh4 NPs). Importantly, AFt-Rh4 NPs not only exhibited excellent antitumor and antimetastatic capabilities against multidrug-resistant NSCLC in vivo but also demonstrated enhanced targeting ability and reduced systemic toxicity and adverse effects. Furthermore, we confirmed and elucidated the mechanisms by which Rh4/AFt-Rh4 NPs inhibit tumor metastasis and reverse MDR in NSCLC. This was achieved by reprogramming the immune and metabolic tumor microenvironments through induction of immunogenic cell death and inhibition of dual-energy metabolism.Keywords
Funding Information
- Natural Science Foundation of Guangxi Zhuang Autonomous Region (2022GXNSFGA035003)
- National Natural Science Foundation of China (22077021)
This publication has 61 references indexed in Scilit:
- Lung cancer statistics, 2023Cancer, 2024
- Mitochondrial Localized In Situ Self‐Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer TherapyAdvanced Materials, 2024
- Nanomedicine Combats Drug Resistance in Lung CancerAdvanced Materials, 2023
- Tumor‐Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma ImmunotherapyAdvanced Materials, 2023
- Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy EfficiencyAdvanced Science, 2022
- A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two‐Photon Photodynamic Therapy Using an Apoptosis–Ferroptosis Hybrid PathwayAngewandte Chemie International Edition, 2022
- A New Strategy to Fight Metallodrug Resistance: Mitochondria‐Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer CellsAngewandte Chemie International Edition, 2022
- Engineering Prodrug Nanomedicine for Cancer ImmunotherapyAdvanced Science, 2020
- Deep Tumor‐Penetrated Nanocages Improve Accessibility to Cancer Stem Cells for Photothermal‐Chemotherapy of Breast Cancer MetastasisAdvanced Science, 2018
- An Apoferritin‐based Drug Delivery System for the Tyrosine Kinase Inhibitor GefitinibAdvanced Healthcare Materials, 2015